Isabel Guisado-Cuadrado, Nuria Romero-Parra, Kirsty J. Elliott-Sale, Craig Sale, Ángel E. Díaz, Ana B. Peinado
{"title":"月经周期和口服避孕药阶段对间歇性跑步时骨(再)塑形标志物的影响","authors":"Isabel Guisado-Cuadrado, Nuria Romero-Parra, Kirsty J. Elliott-Sale, Craig Sale, Ángel E. Díaz, Ana B. Peinado","doi":"10.1007/s00223-024-01259-4","DOIUrl":null,"url":null,"abstract":"<p>To explore how sex hormone fluctuations may affect bone metabolism, this study aimed to examine P1NP and β-CTX-1 concentrations across the menstrual and oral contraceptive (OC) cycle phases in response to running. 17β-oestradiol, progesterone, P1NP and β-CTX-1 were analysed pre- and post-exercise in eight eumenorrheic females in the early-follicular, late-follicular, and mid-luteal phases, while 8 OC users were evaluated during the withdrawal and active pill-taking phases. The running protocol consisted of 8 × 3min treadmill runs at 85% of maximal aerobic speed. 17β-oestradiol concentrations (pg·ml<sup>−1</sup>) were lower in early-follicular (47.22 ± 39.75) compared to late-follicular (304.95 ± 235.85;<i>p</i> = < 0.001) and mid-luteal phase (165.56 ± 80.6;<i>p</i> = 0.003) and higher in withdrawal (46.51 ± 44.09) compared to active pill-taking phase (10.88 ± 11.24;<i>p</i> < 0.001). Progesterone (ng·ml<sup>−1</sup>) was higher in mid-luteal (13.214 ± 4.926) compared to early-follicular (0.521 ± 0.365; <i>p</i> < 0.001) and late-follicular phase (1.677 ± 2.586;<i>p</i> < 0.001). In eumenorrheic females, P1NP concentrations (ng·ml<sup>−1</sup>) were higher in late-follicular (69.97 ± 17.84) compared to early-follicular (60.96 ± 16.64;<i>p</i> = 0.006;) and mid-luteal phase (59.122 ± 11.77;<i>p</i> = 0.002). β-CTX-1 concentrations (ng·ml<sup>−1</sup>) were lower in mid-luteal (0.376 ± 0.098) compared to late-follicular (0.496 ± 0.166; <i>p</i> = 0.001) and early-follicular phase (0.452 ± 0.148; <i>p</i> = 0.039). OC users showed higher post-exercise P1NP concentrations in withdrawal phase (61.75 ± 8.32) compared to post-exercise in active pill-taking phase (45.45 ± 6;<i>p</i> < 0.001). Comparing hormonal profiles, post-exercise P1NP concentrations were higher in early-follicular (66.91 ± 16.26;<i>p</i> < 0.001), late-follicular (80.66 ± 16.35;<i>p</i> < 0.001) and mid-luteal phases (64.57 ± 9.68;<i>p</i> = 0.002) to active pill-taking phase. These findings underscore the importance of studying exercising females with different ovarian hormone profiles, as changes in sex hormone concentrations affect bone metabolism in response to running, showing a higher post-exercise P1NP concentrations in all menstrual cycle phases compared with active pill-taking phase of the OC cycle.</p>","PeriodicalId":3,"journal":{"name":"ACS Applied Electronic Materials","volume":null,"pages":null},"PeriodicalIF":4.3000,"publicationDate":"2024-07-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Influence of Menstrual Cycle and Oral Contraceptive Phases on Bone (re)modelling Markers in Response to Interval Running\",\"authors\":\"Isabel Guisado-Cuadrado, Nuria Romero-Parra, Kirsty J. Elliott-Sale, Craig Sale, Ángel E. Díaz, Ana B. Peinado\",\"doi\":\"10.1007/s00223-024-01259-4\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>To explore how sex hormone fluctuations may affect bone metabolism, this study aimed to examine P1NP and β-CTX-1 concentrations across the menstrual and oral contraceptive (OC) cycle phases in response to running. 17β-oestradiol, progesterone, P1NP and β-CTX-1 were analysed pre- and post-exercise in eight eumenorrheic females in the early-follicular, late-follicular, and mid-luteal phases, while 8 OC users were evaluated during the withdrawal and active pill-taking phases. The running protocol consisted of 8 × 3min treadmill runs at 85% of maximal aerobic speed. 17β-oestradiol concentrations (pg·ml<sup>−1</sup>) were lower in early-follicular (47.22 ± 39.75) compared to late-follicular (304.95 ± 235.85;<i>p</i> = < 0.001) and mid-luteal phase (165.56 ± 80.6;<i>p</i> = 0.003) and higher in withdrawal (46.51 ± 44.09) compared to active pill-taking phase (10.88 ± 11.24;<i>p</i> < 0.001). Progesterone (ng·ml<sup>−1</sup>) was higher in mid-luteal (13.214 ± 4.926) compared to early-follicular (0.521 ± 0.365; <i>p</i> < 0.001) and late-follicular phase (1.677 ± 2.586;<i>p</i> < 0.001). In eumenorrheic females, P1NP concentrations (ng·ml<sup>−1</sup>) were higher in late-follicular (69.97 ± 17.84) compared to early-follicular (60.96 ± 16.64;<i>p</i> = 0.006;) and mid-luteal phase (59.122 ± 11.77;<i>p</i> = 0.002). β-CTX-1 concentrations (ng·ml<sup>−1</sup>) were lower in mid-luteal (0.376 ± 0.098) compared to late-follicular (0.496 ± 0.166; <i>p</i> = 0.001) and early-follicular phase (0.452 ± 0.148; <i>p</i> = 0.039). OC users showed higher post-exercise P1NP concentrations in withdrawal phase (61.75 ± 8.32) compared to post-exercise in active pill-taking phase (45.45 ± 6;<i>p</i> < 0.001). Comparing hormonal profiles, post-exercise P1NP concentrations were higher in early-follicular (66.91 ± 16.26;<i>p</i> < 0.001), late-follicular (80.66 ± 16.35;<i>p</i> < 0.001) and mid-luteal phases (64.57 ± 9.68;<i>p</i> = 0.002) to active pill-taking phase. These findings underscore the importance of studying exercising females with different ovarian hormone profiles, as changes in sex hormone concentrations affect bone metabolism in response to running, showing a higher post-exercise P1NP concentrations in all menstrual cycle phases compared with active pill-taking phase of the OC cycle.</p>\",\"PeriodicalId\":3,\"journal\":{\"name\":\"ACS Applied Electronic Materials\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":4.3000,\"publicationDate\":\"2024-07-27\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"ACS Applied Electronic Materials\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1007/s00223-024-01259-4\",\"RegionNum\":3,\"RegionCategory\":\"材料科学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"ENGINEERING, ELECTRICAL & ELECTRONIC\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACS Applied Electronic Materials","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s00223-024-01259-4","RegionNum":3,"RegionCategory":"材料科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENGINEERING, ELECTRICAL & ELECTRONIC","Score":null,"Total":0}
Influence of Menstrual Cycle and Oral Contraceptive Phases on Bone (re)modelling Markers in Response to Interval Running
To explore how sex hormone fluctuations may affect bone metabolism, this study aimed to examine P1NP and β-CTX-1 concentrations across the menstrual and oral contraceptive (OC) cycle phases in response to running. 17β-oestradiol, progesterone, P1NP and β-CTX-1 were analysed pre- and post-exercise in eight eumenorrheic females in the early-follicular, late-follicular, and mid-luteal phases, while 8 OC users were evaluated during the withdrawal and active pill-taking phases. The running protocol consisted of 8 × 3min treadmill runs at 85% of maximal aerobic speed. 17β-oestradiol concentrations (pg·ml−1) were lower in early-follicular (47.22 ± 39.75) compared to late-follicular (304.95 ± 235.85;p = < 0.001) and mid-luteal phase (165.56 ± 80.6;p = 0.003) and higher in withdrawal (46.51 ± 44.09) compared to active pill-taking phase (10.88 ± 11.24;p < 0.001). Progesterone (ng·ml−1) was higher in mid-luteal (13.214 ± 4.926) compared to early-follicular (0.521 ± 0.365; p < 0.001) and late-follicular phase (1.677 ± 2.586;p < 0.001). In eumenorrheic females, P1NP concentrations (ng·ml−1) were higher in late-follicular (69.97 ± 17.84) compared to early-follicular (60.96 ± 16.64;p = 0.006;) and mid-luteal phase (59.122 ± 11.77;p = 0.002). β-CTX-1 concentrations (ng·ml−1) were lower in mid-luteal (0.376 ± 0.098) compared to late-follicular (0.496 ± 0.166; p = 0.001) and early-follicular phase (0.452 ± 0.148; p = 0.039). OC users showed higher post-exercise P1NP concentrations in withdrawal phase (61.75 ± 8.32) compared to post-exercise in active pill-taking phase (45.45 ± 6;p < 0.001). Comparing hormonal profiles, post-exercise P1NP concentrations were higher in early-follicular (66.91 ± 16.26;p < 0.001), late-follicular (80.66 ± 16.35;p < 0.001) and mid-luteal phases (64.57 ± 9.68;p = 0.002) to active pill-taking phase. These findings underscore the importance of studying exercising females with different ovarian hormone profiles, as changes in sex hormone concentrations affect bone metabolism in response to running, showing a higher post-exercise P1NP concentrations in all menstrual cycle phases compared with active pill-taking phase of the OC cycle.